Subscribe Us

header ads

Recents

header ads

Ambulatory EHR Market Size At Around US$ 9.6 Bn In 2030

The ambulatory EHR market would grow at a CAGR of 5.76% over the predicted time frame. The market is expected to increase in value from US$ 6.13 Bn in 2022 to US$ 9.6 Bn in 2030.

Ambulatory EHR Market Size 2022 To 2030

The on ambulatory EHR Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2311

A recent report provides crucial insights along with application based and forecast information in the Global Ambulatory EHR Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Ambulatory EHR market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Ambulatory EHR market are included as given below:

Ambulatory EHR Market Key Players

  • AdvancedMD, Inc. (U.S.).
  • Allscripts Healthcare Solutions, Inc. (US)
  • Amazing Charts, LLC (The U.S),
  • Athenahealth (The U.S),
  • CareCloud, Inc. (The U.S),
  • Cerner Corporation (US)
  • Computer Programs and Systems, Inc. (US)
  • CureMD Healthcare (The U.S),
  • DrChrono (The U.S),
  • eClinicalWorks (The U.S),
  • eMDs, Inc.
  • Epic Systems Corporation (US)
  • General Electric Company
  • Greenway Health, LLC (The U.S),
  • Healthland
  • Kareo (The U.S),
  • McKesson Corporation
  • Medical Information Technology, Inc. (US)
  • Medical Transcription Billing Corporation
  • Modernizing Medicine, Inc.
  • Netsmart Technologies (The U.S),
  • Nextgen Healthcare Information Systems LLC
  • Practice Fusion Inc.
  • QSI Management, LLC

Market Segments

By Deployment Mode

  • Cloud/Web-based
  • On-premise

By Type

  • All-in-one
  • Modular

By Practice Size

  • Large Practices
  • Small-to-medium-sized Practices
  • Solo Practices

By Application

  • Practice Management
  • Patient Portals
  • Computerized Physician Order Entry (CPOE)
  • Clinical Decision Support (CDS)
  • Population Health Management
  • Referral Management
  • Other Applications

By End User

  • Hospital-owned Ambulatory Centres
  • Independent Ambulatory Centres

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global ambulatory EHR market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the ambulatory EHR market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ambulatory EHR Market 

5.1. COVID-19 Landscape: Ambulatory EHR Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ambulatory EHR Market, By Deployment Mode

8.1. Ambulatory EHR Market, by Deployment Mode, 2022-2030

8.1.1. Cloud/Web-based

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. On-premise

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Ambulatory EHR Market, By Type

9.1. Ambulatory EHR Market, by Type, 2022-2030

9.1.1. All-in-one

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Modular

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Ambulatory EHR Market, By Practice Size 

10.1. Ambulatory EHR Market, by Practice Size, 2022-2030

10.1.1. Large Practices

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Small-to-medium-sized Practices

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Solo Practices

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Ambulatory EHR Market, By Application

11.1. Ambulatory EHR Market, by Application, 2022-2030

11.1.1. Practice Management

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Patient Portals

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Computerized Physician Order Entry (CPOE)

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Clinical Decision Support (CDS)

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Population Health Management

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Referral Management

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Ambulatory EHR Market, By End User

12.1. Ambulatory EHR Market, by End User, 2022-2030

12.1.1. Hospital-owned Ambulatory Centres

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Independent Ambulatory Centres

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Ambulatory EHR Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.1.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.1.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.2.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.2.4. Market Revenue and Forecast, by Application (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.2.7. Market Revenue and Forecast, by Application (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.2.10. Market Revenue and Forecast, by Application (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.3.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.3.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.4.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.4.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.5.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.5.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. AdvancedMD, Inc. (U.S.)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Allscripts Healthcare Solutions, Inc. (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Amazing Charts, LLC (The U.S)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Athenahealth (The U.S)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. CareCloud, Inc. (The U.S)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Cerner Corporation (US)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Computer Programs and Systems, Inc. (US)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. CureMD Healthcare (The U.S)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. DrChrono (The U.S)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. eClinicalWorks (The U.S)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

Post a Comment

0 Comments